Merck

YORK, 20-Jul-2016 — /EuropaWire/ — A University of York chemist, whose research has made important contributions to the development of flat-screen displays for TVs, computers and mobile phones, has been awarded a prestigious Royal Medal of the Royal Society. Professor John … Read the full press release →

First Phase III trial evaluating the addition of an immune checkpoint inhibitor to standard of care in first-line ovarian cancer New investigational regimen will evaluate avelumab in extending progression-free survival in treatment-naïve women Darmstadt, Germany and New York, US, 07-Jul-2016 … Read the full press release →

Investment reflects company’s commitment to innovation in fertility research Globally, six projects receive funding from this grant cycle Darmstadt, Germany, 07-Jul-2016 — /EuropaWire/ — Merck, a leading science and technology company, today announced it would continue to support the advancement of … Read the full press release →

GSK3359609 is the first investigational ICOS agonist antibody to enter human clinical trials LONDON, 01-Jul-2016 — /EuropaWire/ — GSK today announced the start of a phase I clinical trial with GSK3359609, an investigational inducibile T-cell costimulator (ICOS) agonist antibody. ICOS is … Read the full press release →

OCREVUS is the first investigational medicine seeking marketing authorisation for both relapsing and primary progressive multiple sclerosis (MS) FDA grants Priority Review Designation for OCREVUS Biologics License Application (BLA) BASEL, 29-Jun-2016 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced … Read the full press release →

Merck obtains global marketing and commercialization rights for the innovative Progyny Eeva® software offering, aiming to provide customers worldwide with innovative fertility technologies solutions This new agreement builds on the successful relationship between both leaders in fertility technologies, first established … Read the full press release →

Werner Wenning to step down as Supervisory Board Chairman after the Annual General Meeting, Karl-Ludwig Kley proposed as successor Düsseldorf, 09-Mar-2016 — /EuropaWire/ — The Supervisory Board Chairman of E.ON SE, Werner Wenning, will end his service at the end of … Read the full press release →

Focus on the Life Sciences following the successful stock market flotation of Covestro / Substantial sales and earnings increases at HealthCare / Good business development at CropScience despite a weaker market environment / Covestro posts strong earnings improvement / Group … Read the full press release →

Darmstadt, Germany, and Rehovot, Israel, 18-Feb-2016 — /EuropaWire/ — Merck, a leading science and technology company, announced that the Weizmann Institute, Rehovot, Israel, conferred the renowned Weizmann Award in the Sciences and Humanities on Karl-Ludwig Kley, CEO and Chairman of the … Read the full press release →

Darmstadt, Germany, and Rehovot, Israel, 18-Feb-2016 — /EuropaWire/ — Merck, a leading science and technology company, today extended the partnership with Weizmann Institute of Science, Rehovot, Israel, of by signing a new framework agreement, building on a successful innovation partnership of … Read the full press release →

BRUSSELS, 18-6-2015 — /EuropaWire/ — The European Commission has approved the proposed acquisition of Sigma-Aldrich by Merck under the EU Merger Regulation. Both companies are active world-wide in the life science sector. The decision is conditional on the divestment of … Read the full press release →

Gütersloh, Germany, 7-5-2015 — /EuropaWire/ — The Bertelsmann SE & Co. KGaA Annual General Meeting today elected the Israeli entrepreneur and investor Gigi Levy-Weiss (44) as a new member of the company’s Supervisory Board. Gigi Levy-Weiss is an angel investor … Read the full press release →

LONDON, 7-4-2015 — /EuropaWire/ — Maris Interiors LLP has completed an office design & relocation project for MSD in London. This project is at the new office space at 2 Pancras Square in London. Merck, Sharp & Dohme appointed Maris … Read the full press release →

HealthCare striving for strong sales and margin growth through 2017 / CropScience aims to grow faster than the market and maintain margin at a high level Leverkusen/Berlin, 13-3-2015 — /EuropaWire/ — The Bayer Group aims to achieve strong sales and earnings … Read the full press release →

The new RebiSmart® injection device offers many new updates including wireless transmission of injection times and doses MSdialog™software is designed to more effectively engage people with MS and their health care providers with treatment adherence information and health related outcome reports … Read the full press release →

Darmstadt, Germany, 17-7-2014 — /EuropaWire/ — Merck Serono, the biopharmaceutical division of Merck, today announced the appointment of Luciano Rossetti, M.D., as Executive Vice President and Global Head of Research & Development as of July 21, 2014. In his most recent role … Read the full press release →

FDA clearance validates Eeva System, which enables in-vitro fertilization (IVF) clinicians to offer the proprietary Eeva Test and further demonstrates commitment by Merck Serono and Auxogyn to bring innovative technologies to the IVF community Eeva Test first-of-a-kind prognostic, non-invasive test that provides IVF clinicians … Read the full press release →

• Darmstadt-based company holds global rights to the name Merck with exception of the U.S. and Canada Darmstadt, Germany,  7-5-2014 — /EuropaWire/ — Merck, the supplier of top-quality high-tech products in the pharmaceuticals and chemicals sectors, today clarified that it will … Read the full press release →

Scientists engaged in collaborative initiatives can now securely access Transformative Cloud-based solution  London, 1-5-2014 — /EuropaWire/ — BT and Exostar, LLC announced today that Exostar is joining the BT for Life Sciences ecosystem as a Strategic Member. The two companies will be … Read the full press release →

• The ESPART* Phase III clinical study focuses on patients that respond poorly to attempts at ovarian stimulation • Study aims to recruit 946 patients across 17 European countries Darmstadt, Germany, 28-3-2014 — /EuropaWire/ — Merck, the global pharmaceutical and chemical company, … Read the full press release →